Basic Study
Copyright ©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 103616
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.103616
Figure 6
Figure 6 Mechanism of glucose disorder amelioration by bile powder-mediated intestinal glucagon-like peptide-1 secretion. Our study revealed that bile powder interacts with the intestinal enteroendocrine L cells to inhibit farnesoid X receptor signaling and to promote glucagon-like peptide-1 production. Bile powder is a glucagon-like peptide-1 stimulator and attenuates blood glucose impairment. GLP-1: Glucagon-like peptide-1; FXR: Farnesoid X receptor.